HEALTHCARE & LIFE SCIENCES

Specialized Healthcare M&A Delivered by
Industry Practitioners

From digital health and revenue cycle management to pharmacy benefits and life sciences — N2M Capital brings operator-led M&A expertise to one of the most complex and relationship-driven sectors in the market.

Institutional M&A Advisory Rooted in Thirty Years of Healthcare Heritage.

Founded by Healthcare Operators. Built for Institutional Results.

N2M Capital is a premier middle-market investment bank built on a foundation of operational excellence within the world’s most complex medical organizations. Founded and led by healthcare veterans formerly with Eli Lilly, Boston Scientific, and McKesson, we provide the technical depth and senior-led advisory required to navigate high-stakes transactions.

Para 2: We bridge the gap between clinical complexity and financial valuation — ensuring that the operational integrity of your platform is fully realized and defended in the eyes of Strategic Acquirers and Private Equity.

Our Strategic Focus Areas

Deep Domain Expertise Across Healthcare & Life Sciences

Leveraging decades of clinical and operational domain expertise to drive transactional certainty. N2M Capital’s healthcare practice is built on 30+ years of hands-on experience inside the world’s most complex medical organizations — including Eli Lilly, Boston Scientific, and McKesson. We don’t just understand the financials — we understand the businesses we represent from the inside out.

01

Healthcare & Health-Tech Services

Platform M&A Advisory

We prepare established, tech-enabled healthcare service providers for rigorous institutional scrutiny to secure premium multiples.

Health-IT & RCM Platforms

Strategic advisory for interoperability, telehealth, and revenue cycle platforms — optimizing for Rule of 40 performance to attract top-tier global acquirers.

Specialized Healthcare MSP

Leveraging our MSP veteran heritage to advise IT providers serving the healthcare sector on HIPAA compliance and recurring revenue stability.

02

Medical Technology (MedTech) & Distribution

MedTech M&A & Recapitalization

Drawing on our roots in cardiology and surgical innovation, we advise established MedTech firms on strategic exits and growth-capital initiatives.

Medical Device Distribution

Specialized M&A for medical device and equipment distribution platforms — where operational scale and GPO relationships drive premium valuations.

Logistics & Supply Chain

Specialized M&A for medical distribution and pharmaceutical logistics assets, built on our team’s deep executive experience at McKesson.

03

Pharma Services & Life Sciences

Pharma-Services & CRO Advisory

Providing institutional-grade rigor to the exit strategies of clinical research organizations and biopharma service platforms.

Pharmacy Benefits & Cost Containment

Advisory for specialty pharmacy benefits platforms and cost-containment businesses serving self-funded employers — one of the fastest-growing segments in healthcare services M&A.

Global Strategic Transactions

Utilizing our veteran experience at Eli Lilly to guide established life science firms through complex cross-border transactions and strategic consolidations.

04

Behavioral Health & Specialty Care

Behavioral Health Platforms

Advisory for established behavioral health and mental health service platforms pursuing institutional capital or strategic exits in one of healthcare’s most active M&A sectors.

Specialty Care & Physician Groups

M&A advisory for specialty care providers and multi-site physician groups navigating PE partnership, recapitalization, or full strategic sale.

Home Health & Care Continuum

Advising home health, hospice, and care continuum businesses on exits and growth transactions as the shift to value-based care accelerates consolidation.

05

Healthcare IT & Cybersecurity

HIPAA & Compliance Platforms

M&A advisory for healthcare compliance and data governance platforms — where regulatory complexity creates defensible moats and premium buyer interest.

Healthcare Cybersecurity & MSSP

Specialized advisory for MSSPs and cybersecurity firms serving the healthcare sector — where data breach exposure and regulatory scrutiny drive strategic consolidation.

Clinical Data & Interoperability

Advisory for health data platforms, EHR integrators, and interoperability solutions positioned at the intersection of clinical operations and enterprise technology.

Serving the Full Healthcare Ecosystem

From established life sciences platforms to tech-enabled healthcare services — N2M Capital brings 30+ years of operator credibility and institutional rigor to every transaction.

Schedule a Consultation

MIDDLE-MARKET M&A ADVISORY DELIVERED BY FORMER HEALTHCARE EXECUTIVES.

Decades of Experience Advising the World's Leading Healthcare Platforms.

30 Yrs Of Operational Pedigree
At N2M Capital, we leverage decades of industry experience to provide the specialized "Technical Source of Truth" that generalist banks miss. Our partners have managed global scale for industry titans — from pioneering EMR adoption to launching innovative cardiology devices into global distribution. We translate these complex clinical moats into the sophisticated financial language required to secure market-leading valuations for middle-market healthcare enterprises.